Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/1999
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999CA2331253A1 Immunomodulator polypeptide, zsig57
12/23/1999CA2331197A1 Hiv virus mimotopes
12/23/1999CA2331154A1 Polypeptides having sequence identity with acid labile subunit of insulin-like growth factor
12/23/1999CA2331153A1 Method for obtaining modified polysaccharides
12/23/1999CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999CA2330933A1 Methods and means for expression of mammalian polypeptides in monocotyledonous plants
12/23/1999CA2330923A1 Vector construction by host cell-mediated recombination
12/23/1999CA2330842A1 Truncated apaf-1 and methods of use thereof
12/23/1999CA2330840A1 Diagnostic method based on quantification of extramitochondrial dna
12/23/1999CA2330732A1 Detection of non-viral organisms with srp rna
12/23/1999CA2330730A1 Materials and methods for amplifying and enhanced transcribing of polynucleotides in plants and portions thereof
12/23/1999CA2330550A1 Plant pathogen inducible control sequences operably linked to cell cycle genes and the uses thereof
12/23/1999CA2330544A1 A novel gene and method of treating a gram negative bacterial infection
12/23/1999CA2330527A1 Erythropoietin analog-human serum albumin fusion
12/23/1999CA2330228A1 Angiostatin-binding protein
12/23/1999CA2330210A1 Proteasomal activity
12/23/1999CA2330209A1 Recombinant production of toxoplasma sag1 antigen
12/23/1999CA2329774A1 Genes for the biosynthesis of epothilones
12/23/1999CA2329689A1 Composition and method for treatment of pseudomonas
12/22/1999EP0965648A1 Method for genomic typing of the Minor Histocomptability Antigen HA-1.
12/22/1999EP0965646A1 PROBES FOR DETECTING AND IDENTIFYING $i(HELICOBACTER PYLORI)
12/22/1999EP0965644A2 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/22/1999EP0965643A1 Mobile genetic elements as tools for genetic modification of L. delbrueckii or L. helveticus
12/22/1999EP0965642A1 Cloning vector, its production and use for the analysis of mRNA expression pattern
12/22/1999EP0965641A2 Integrative gene-expression in food-grade microorganisms
12/22/1999EP0965640A1 GP75 as a tumor vaccine for melanoma
12/22/1999EP0965639A1 Attenuated pestiviruses
12/22/1999EP0965638A2 G-CSF analog compositions and methods
12/22/1999EP0965637A1 Fas ANTIGEN DERIVATIVES
12/22/1999EP0965636A1 Oligonucleotides used for detecting vibrio parahaemolyticus and method of detection therewith
12/22/1999EP0965634A1 Novel primer and use thereof
12/22/1999EP0965597A1 Cell membrane-directed drugs
12/22/1999EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999EP0965584A2 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999EP0965583A1 Polyamine compounds and compositions containing them useful for the transfer of active substances into a cell
12/22/1999EP0965336A1 Microencapsulated DNA for gene therapy
12/22/1999EP0965265A2 AHAS-inhibiting herbicide resistant wheat and method for selection thereof
12/22/1999EP0964934A1 Method and device for refining nucleic acids
12/22/1999EP0964933A1 Method and kit for diagnosis of an increased risk of cardiovascular diseases
12/22/1999EP0964930A1 Catalytic rna molecules
12/22/1999EP0964929A1 Mismatch endonucleases and uses thereof in identifying mutations in targeted polynucleotide strands
12/22/1999EP0964927A1 Cassava vein mosaic virus promoters and uses thereof
12/22/1999EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999EP0964924A1 Iron regulated promoter and uses thereof
12/22/1999EP0964923A1 A process for the purification of plasmid dna
12/22/1999EP0964922A1 Methods for optimization of gene therapy by recursive sequence shuffling and selection
12/22/1999EP0964921A1 Novel streptococcal ers
12/22/1999EP0964920A1 Methods for improving seeds
12/22/1999EP0964918A2 Reversibly inactive synthetic beta-galactosidase
12/22/1999EP0964917A1 Age-1 polypeptides and related molecules and methods
12/22/1999EP0964916A1 Viral variants and methods for detecting same
12/22/1999EP0964914A1 Soybean cysteine proteinase inhibitors, nucleotides encoding the same, and methods of use thereof
12/22/1999EP0964875A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
12/22/1999EP0964874A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
12/22/1999EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999EP0964869A1 Methods and compositions for generating angiostatin
12/22/1999EP0964701A1 Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
12/22/1999EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
12/22/1999EP0964696A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
12/22/1999EP0964694A1 Mucin-mediated immunomodulation
12/22/1999EP0964693A1 Novel bacteriocins, transport and vector system and method of use thereof
12/22/1999EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms
12/22/1999EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions
12/22/1999EP0876160B1 Ligand directed enzyme prodrug therapy
12/22/1999EP0785992A4 Conditional transformation of genetically engineered cells
12/22/1999EP0752007A4 Thermodynamics, design, and use of nucleic acid sequences
12/22/1999EP0726954B1 Cytokine antagonists
12/22/1999CN1239514A Encapsulation of polypeptides within starch matrix
12/22/1999CN1239513A Method for selecting transformed cells
12/22/1999CN1239512A Replication-competent recombinant sabin type 1 strain of pollovirus
12/22/1999CN1239511A Method for prodn. of 1,3-propanediol by recombinant organisms
12/22/1999CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999CN1239509A Waxy wheat starch types having waxy proteins in granule
12/22/1999CN1239479A Mage-1- encoding cDNA, tumor rejection antigen precursor mage-10, antibodies specific to molecule, and uses thereof
12/22/1999CN1239143A Method for producing nucleic acid substances
12/22/1999CN1239142A Cytochrome BD type quinol oxidase gene of brevibacterium lactofermentum
12/22/1999CN1239141A Resveratrol synthase gene and its preparing process
12/22/1999CN1239103A Process for preparing recombined human serum albumin
12/22/1999CN1047666C Immunity detection method of releasing antigen from antibodies
12/22/1999CN1047630C Method and reagents for hepatitis C detection
12/22/1999CA2246892A1 Cryptic regulatory elements in plants
12/21/1999US6005167 Polynucleotide of a promoter active in anthers linked to the inhibitory gene encoding a rna or polypeptide which targets enzyme in the chalcone biosynthesis pathway; for production of hybrid seed
12/21/1999US6005166 Papaya ringspot virus replicase gene
12/21/1999US6005096 For oligonucleotides that are modified to enhance the binding affinity and to bear detectable labels; for diagnostic use
12/21/1999US6005095 Antisense agents; antitumor agents
12/21/1999US6005092 Arabidopsis thaliana endo-1,4-β-glucanase gene and promoter
12/21/1999US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999US6005089 Nucleotide sequence which hybridizes to major platelet membrane protein; for diagnosis and gene therapy of related diseases; for detection of cells of megakaryoblastic lineage in humans
12/21/1999US6005087 Nuclease resistant oligonucleotides which are useful as therapeutics, diagnostics, and research reagents for various viral diseases
12/21/1999US6005086 Wherein said polypeptide is a nuclear receptor and is responsive to the presence of farnesoid to regulate the transcription of associated gene(s)
12/21/1999US6005082 Process for purification of factor VIII
12/21/1999US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999US6005074 Cloning of human GPR14 receptor
12/21/1999US6005072 Proteins closely related to opioid receptors
12/21/1999US6004944 Protein delivery by secretory gland expression
12/21/1999US6004942 Administering viral vector to joint comprising nucleic acid sequence encoding polypeptide; gene expression
12/21/1999US6004941 Introducing nucleic acid encoding fusion protein which activates transcription and comprises a polypeptide that binds to tetracycline operator
12/21/1999US6004940 Gene expression; nucleic acid segment encoding variable heavy chain sequence of antibody which selectively binds antigen
1 ... 3309 3310 3311 3312 3313 3314 3315 3316 3317 3318 3319 3320 3321 3322 3323 3324 3325 3326 3327 3328 3329 ... 4023